ACONW
Aclarion IncKey Statistics
About Aclarion Inc
Aclarion Inc (ACONW) is a cutting-edge healthcare technology firm dedicated to revolutionizing the diagnosis and management of musculoskeletal disorders through advanced non-invasive imaging solutions. By leveraging proprietary algorithms and sophisticated data analytics, Aclarion empowers healthcare providers with actionable insights that enhance personalized patient care and optimize clinical workflows. Positioned as a leader in the healthcare diagnostics arena, the company is committed to innovating medical imaging standards while addressing the dynamic needs of patients and practitioners alike. With a strategic focus on market expansion, Aclarion aims to drive significant improvements in patient outcomes through its transformative solutions.
Fundamentals
| Revenue (TTM) | 83,770 |
| Gross Profit (TTM) | 18,220 |
| EBITDA | $-9.47M |
| Operating Margin | -11503.00% |
| Return on Equity | -59.00% |
| Return on Assets | -37.00% |
| Revenue/Share (TTM) | $0.06 |
| Book Value | $6.91 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 30.50% |
| Shares Outstanding | 0 |
| Float | $2.62M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
Volatility is currently expanding
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ACONW and any ticker you trade — then tracks every position and per-strategy win rate.